---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-027390"
form_type: "8-K"
ticker: "CRVS"
cik: "0001626971"
company_name: "Corvus Pharmaceuticals, Inc."
filed_at: "2026-03-13T23:59:59+00:00"
generated_at: "2026-05-15T12:36:47.461441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Corvus ups at-the-market equity facility to $200M from $100M

## Summary
- Amended Sales Agreement with Jefferies allows up to $200M in common stock sales, increased from $100M.
- No shares sold under prior $100M agreement; new ATM offering uses customary terms.
- Jefferies to receive up to 3.0% commission; agreements include representations and indemnification.
- Prospectus supplement filed; sales may be in negotiated, block, or ATM transactions.

## SEC filing metadata
- accession: 0001104659-26-027390
- form_type: 8-K
- ticker: CRVS
- cik: 0001626971
- company_name: Corvus Pharmaceuticals, Inc.
- filed_at: 2026-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/0001104659-26-027390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/tm268518d4_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-027390
- JSON: https://secwatch.observer/filing/0001104659-26-027390.json
- Plain text: https://secwatch.observer/filing/0001104659-26-027390.txt

## Key facts
- Material Agreements
  Corvus Pharmaceuticals, Inc. entered into Amended and Restated Open Market Sale Agreement with Jefferies LLC valued at maximum aggregate offering price of up to $200,000,000 (effective 2026-03-13).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: maximum aggregate offering price of up to $200,000,000
  - Effective: 2026-03-13
  source text: On March 13, 2026, the Company entered into an Amended and Restated Open Market Sale Agreement SM (the “Amended Sales Agreement”), with Jefferies LLC (“Jefferies”), to sell shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), from time to time through Jefferies acting as sales agent, having a maximum aggregate offering price of up to $200,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626971/000110465926027390/0001104659-26-027390-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.